X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (350) 350
Publication (29) 29
Book Chapter (9) 9
Conference Proceeding (8) 8
Book / eBook (7) 7
Book Review (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (105) 105
humans (99) 99
index medicus (91) 91
adult (62) 62
male (58) 58
middle aged (46) 46
hemophilia (44) 44
female (42) 42
operations research & management science (41) 41
hemophilia a - drug therapy (38) 38
young adult (38) 38
analysis (35) 35
haemophilia (33) 33
algorithms (32) 32
adolescent (30) 30
aged (30) 30
optimization (30) 30
therapy (29) 29
child (27) 27
rehabilitation (26) 26
haemophilia a (24) 24
studies (24) 24
physics, atomic, molecular & chemical (23) 23
treatment outcome (23) 23
factor viii - therapeutic use (22) 22
blood coagulation factor viii (20) 20
peripheral vascular disease (19) 19
prophylaxis (19) 19
safety (19) 19
inhibitors (18) 18
care and treatment (17) 17
chemistry, physical (17) 17
usage (17) 17
efficacy (16) 16
engineering, biomedical (15) 15
mathematics, applied (15) 15
research (15) 15
child, preschool (14) 14
epidemiology (14) 14
factor-viii (14) 14
hemophilia a - complications (14) 14
risk factors (14) 14
clinical trials (13) 13
operations research/decision theory (13) 13
prospective studies (13) 13
recombinant proteins - therapeutic use (13) 13
computer science, interdisciplinary applications (12) 12
dynamics (12) 12
europe (12) 12
factor viii (12) 12
infant (12) 12
management (12) 12
molecules (12) 12
pharmacokinetics (12) 12
economics / management science (11) 11
hemophilia a - immunology (11) 11
hydrogen (11) 11
medicine & public health (11) 11
methods (11) 11
patients (11) 11
robotics (11) 11
robots (11) 11
610 medicine & health (10) 10
approximation (10) 10
bleeding (10) 10
chemistry, multidisciplinary (10) 10
factor viii - immunology (10) 10
germany (10) 10
hemophilia a - therapy (10) 10
retrospective studies (10) 10
aged, 80 and over (9) 9
balgrist university hospital, swiss spinal cord injury center (9) 9
facility location (9) 9
forbidden regions (9) 9
neurosciences (9) 9
operations research (9) 9
quality of life (9) 9
recombinant factor-viii (9) 9
severity of illness index (9) 9
surveys and questionnaires (9) 9
travel (9) 9
children (8) 8
clinical medicine (8) 8
exercise (8) 8
factor viii - administration & dosage (8) 8
ionization (8) 8
materials science, multidisciplinary (8) 8
pediatrics (8) 8
photochemistry (8) 8
physics, condensed matter (8) 8
stroke (8) 8
surveys (8) 8
thrombosis (8) 8
adults (7) 7
diagnosis (7) 7
dynamic programming (7) 7
engineering, industrial (7) 7
factor viii - adverse effects (7) 7
hemophilia a - diagnosis (7) 7
hemophilia b - drug therapy (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haemophilia, ISSN 1351-8216, 09/2017, Volume 23, Issue 5, pp. 697 - 704
Journal Article
THROMBOSIS RESEARCH, ISSN 0049-3848, 11/2014, Volume 134, pp. S38 - S42
Introduction: Beriate (R) P was first introduced in Germany in 1990 as factor VIII (FVIII):C (R) HS Behring and subsequent product improvements yielded an... 
Plasma derived | CLINICAL-EVALUATION | Factor VIII | RECOMBINANT FACTOR-VIII | PREVIOUSLY UNTREATED PATIENTS | Beriate (R) P | Haemophilia A | REMOVAL | PRODUCTS | VIRUS SAFETY | FACTOR-IX | PERIPHERAL VASCULAR DISEASE | INHIBITOR DEVELOPMENT | ABSENCE | HEMATOLOGY | Coagulation factor | Recombinant | PREVIOUSLY TREATED PATIENTS
Journal Article
Thrombosis Research, ISSN 0049-3848, 11/2014, Volume 134, p. S16-S21
The German Beriate.sup.[R] P pharmacovigilance study started in 2003 and is planned to run until December 2013. 
Care and treatment | Hemophilia
Journal Article
Journal Article
Journal Article
THERAPEUTIC ADVANCES IN HEMATOLOGY, ISSN 2040-6207, 06/2019, Volume 10, p. 2040620719858471
Simoctocog alfa (human-cl rhFVIII, Nuwiq (R)) is a 4th generation recombinant FVIII (rFVIII), without chemical modification or fusion with any other... 
coagulation disorders | FC FUSION PROTEIN | COAGULATION-FACTOR-VIII | simoctocog alfa | RECOMBINANT FACTOR-VIII | Nuwiq (R) | ON-DEMAND TREATMENT | PREVIOUSLY UNTREATED PATIENTS | HUMAN-CL RHFVIII | HUMAN CELL-LINE | PROPHYLACTIC TREATMENT | clinical trials | INHIBITOR DEVELOPMENT | QUALITY-OF-LIFE | HEMATOLOGY
Journal Article
by Visigalli, I and Cecere, F and Carriglio, N and Hernandez, R J and Hernandez, R J and De Simone, M and Vezzoli, M and Monti, L and Zino, E and Alfonso, E and Sanvito, F and Mauro, V and Norata, R and Acquati, S and Acquati, S and Redaelli, D and Redaelli, D and Dionisio, F and De Mattia, F and Scaramuzza, S and Rossi, C and Giannelli, S and Giannelli, S and Salerio, F and Sartirana, C and Brigida, I and Magni, S and Miglietta, S and Monteverde, S and Monti, I and Gregori, S and Ferrari, G and Aiuti, A and Castagnaro, L and Zancan, S and Cristofori, P and Naldini, L and Bonini, C and Waselle, L and Tissot, L and Sitjve, S and Büning, H and Ayuso, E and Déglon, N and Bueren, J and Trono, D and Nobrega, C and Mendonça, L and Marcelo, A and Lamazière, A and Tomé, S and Tomé, S and Déspres, G and Matos, C and Mechmet, F and Langui, D and den Dunnen, W and Pereira de Almeida, L and Cartier, N and Mitchell, J and Nemesh, J and Ghosh, S and Mello, C and McCaroll, S and Di Pasquale, G and Chandler, R J and Choi, E Y and Hubbard, B and Afione, S and Khalaj, M and Zheng, C and Grewe, B and Kaler, S G and Venditti, C P and Grimm, D and Grimm, D and Buj Bello, A and Nyns, E CA and Bingen, B O and Bart, C I and Kip, A and Poelma, R H and Volkers, L and Plomp, J J and Jangsangthong, W and Engels, M C and Schalij, M J and Zhang, G Q and Pijnappels, D A and Hildebrant, E and Penzes, J and Agbandje-McKenna, M and Gifford, R and Xiao, X and Akcakaya, P and Bobbin, M L and Guo, J A and Malagon-Lopez, J and Clement, K and Garcia, S P and ...
Human Gene Therapy, ISSN 1043-0342, 12/2018, Volume 29, Issue 12, pp. A1 - A169
Previously, results at 2 years after subretinal injection of a recombinant adeno-associated virus vector expressing RPE65 (rAAV2-CB-hRPE65) in eight adults and... 
Abstracts | MEDICINE, RESEARCH & EXPERIMENTAL | retinal degeneration | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | AAV | GENETICS & HEREDITY | gene therapy | Leber congenital amaurosis | RPE65
Journal Article
Hamostaseologie, ISSN 0720-9355, 2017, Volume 37, Issue 3, pp. 216 - 218
Treatment and prevention of bleeding episodes in patients with severe haemophilia A require frequent intravenous injection of factor VIII. Inhibitory... 
Haemophilia A | Inhibitor | Bispeci - fic antibody | Prophylaxis | bispecific antibody | haemophilia A | inhibitor | HEMATOLOGY | prophylaxis | ACE910
Journal Article